Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy". Naganuma M. J Gastroenterol 2024 May 13. doi: 10.1007/s00535-024-02113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Naganuma M. Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy". J Gastroenterol 2024 May 13. doi: 10.1007/s00535-024-02113.
PMID: 38739201